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CHAPTER I 
INTRODUCTION 
In 1934, Lohmann and Meyerhof (1) and Parnas et al. (2) reported a 
previously unrecognized intermediate in the conversion of 3 phosphogly-
-++ 
cerate to pyruvate in the presence of adenine nucleotides and Mg • In 
their classical work, Lohmann and Meyerhof were successful in the isola-
tion and determination of the structure of phosphoenol pyruvate, but 
noted the adenine nucloeotides only as a coenzyme concluding that the 
degradation of phosphoenol pyruvate gave orthophosphate and pyruvate 
(1). Parnas et al. (2) concluded from their observation that creatine 
was the acceptor of the phosphoryl group from phosphoenol pyruvate (3). 
In July of the next year H. Lehman, C. Lufwak - Mann & T. Mann, and 
D. M. Needham & W. E. Van Heyningen independently produced evidence for 
the phosphorylation of AMP by PEP to give ATP (4,5,6). However, the 
lower initial rate of phosphorylation of AMP as compared to ADP (7) and 
recognition of ADP as the phosphoryl acceptor of 1,3 diphosphoglycerate 
(8) suggested ADP as the more likely acceptor of PEP's phosphoryl group. 
In addition the discovery of adenylate kinase gave a reasonable explan-
ation for AMP phosphorylation. Finally, ADP won as the phosphoryl group 
acceptor from PEP by default when purified pyruvate kinase failed to 
phosphorylate AMP (9). 
The first purification of pyruvate kinase is credited to Negelein 
(10) but his protocols and manuscripts related to the work were lost at 
1 
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the end of W. W. II in the mass confusion. In spite of this misfortune, 
the enzyme was purified from rabbit muscle (10,11,12), from human muscle 
(13) and from cat muscle (14). As acceptable methods for purification 
were devised and the muscle enzyme was purified from different sources, 
other biochemical properties were being explored. + K as well as other 
monovalent cations were found to be activators and ATP an inhibitor. 
Molecular weight, apparent equilibrium constants and other properties 
were also determined. 
In 1965 three laboratories, Krebs and Eggleston (15), Weber et al. 
(16), and Tanaka et al. (17) showed that pyruvate kinase of liver was 
under dietary and hormonal regulation. Tanaka et al. (18) noting that 
in contrast skeletal muscle was not regulated in this manner proceeded 
with a series of experiments using zone electrophoresis and irnmunologi-
cal methods to show that there existed at least two types of pyruvate 
kinase which he dubbed M (muscle) and L (liver) types based on antibody 
response. 
It should be mentioned that there is some controversy about nomeri-
clature for the isozymes of pyruvate kinase. The nomenclature used 
herein is not in accordance with IUPAC-IUB but, agrees with the choice 
of Strandholm, Cardenas and Dyson (19). 
Two years later in 1967, Tanaka et al. (20) purified to crystalline 
form the Mand L isozymes of pyruvate kinase from rat liver. Also pre-
sented in the paper were kinetic studies, additional data on dietary and 
hormonal effects, further immunological studies and distribution of the 
two types of pyruvate kinase in other organs. In the same year follow-
ing a lead from Hess et al. (21) who published evidence for fructose 
1,6-diphosphate activation of yeast pyruvate kinase and Taylor & Bailey's 
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(22) work showing fructose 1,6-diphosphate activation only in pyruvate 
kinase extracted from liver,' Tanaka et al. (23) investigated fructose 
1,6-diphosphate effects on purified type L enzyme. The studies by 
Tanaka's group verified the activation of type L enzyme from liver by 
fructose 1,6-diphosphate, but type L enzyme from erythrocytes did not 
show activation by fructose 1,6-diphosphate. Equally important was the 
observation that fructose 1,6-diphosphate could significantly reverse 
the previously shown inhibition of activity by ATP. 
In 1969, H. Carminatti, E. Rozengurt & L. Jimenez de Asua (24) 
published a paper in which they described the successful elution of 
type L pyruvate kinase from CM cellulose by its allosteric effectors. 
The enzyme was purified 30 fold with 60% recovery. Also, this proce-
dure provided an alternative to the Tanaka et al. (20) separation of 
the two types of liver enzyme. The type L was removed with an effector; 
the type M was not, but could be removed with 120 mM Tris-maleate. 
The following year, G. E. J. Stall et al. (25) and K. G. Blume et 
al. (26) used the Haeckel et al. (27) technique (with some modification) 
for the purification of human erythrocyte pyruvate kinase. This in-
volved the reversible binding of Blue Dextran to the type L pyruvate 
kinase. This serendipidous event was then used to purify the enzyme 
by passing the Blue Dextran-enzyme complex over a Sephadex G-200 col-
umn. After disassociating the complex the enzyme and Blue Dextran were 
again passed through the G-200 column. A purification of approximately 
ten to thirty thousand (cumulative) fold was achieved. 
In 1972, another method for human erythrocyte pyruvate kinase pur-
ification was reported by C. Chern, M. B. Rittenberg and J. A. Black 
(28) using the method of Carminatti et al. (24). 
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In the next year J. Cardenas & R. Dyson (29,30,31) published three 
excellent papers on purification of bovine skeletal muscle and liver 
pyruvate kinase and hybridization studies of the two isozymes. The pur-
ification .of type L followed closely the scheme of Tanaka et al. (20) 
but included the use of a Sephadex G-200 column in the culminating step. 
Finally, at the University of Uppsala in Sweden, 1974, Engstrom 
et al. (32) devised yet another method for type L purification and pre-
sented evidence which suggested that the type L enzyme may be phosphory-
lated by ( 35P) ATP and cyclic AMP stimulated protein kinase. The au-
thors suggest that type L pyruvate kinase belongs to the group of en-
zymes whose activity is regulated by phosphorylation-dephosphorylation 
reactions. 
The purification scheme presented by Engstrom et al. (32) is some-
what different from previous attempts. Advantage was taken of pyruvate 
kinase stability to lower pH and allosteric effectors were used to re-
tain the enzyme on a DEAE-cellulose column under two sets of conditions. 
Also, Hydroxylapatite was used to gain significant purification. 
Historically, the purification of type L pyruvate kinase has been 
plagued with the problem of poor yield, tediousness of the process and 
instability of the enzyme. Moreover, there have been several reports 
(22,33,34,35) of changes in enzymatic activity and/or susceptibility to 
modifiers. 
Due to the extensive research being done in this area a simplified 
procedure with better yields and stability would be a significant con-
tribution to researchers. For these reasons the present study was un-
dertaken. 
CHAPTER II 
MATERIALS AND METHODS 
Materials 
Agarose-Hexane-AMP (adenine N6 -amino linkage), Agarose-Hexane-ATP 
(ribose hydroxl linkage) and Agarose-Hexane-AMP (ribose hydroxl linkage) 
were from P. L. Biochemicals, Inc. 1,4-diaminobutane, 1,5-diaminopent-
ane and 1,6-diaminohexane were supplied by Aldrich. MgS04, (NH4)2S04, 
Tris, and Na2EDTA were obtained from Schwartz/Mann. Cyanogen Bromide 
activated Sepharose 4B, Sepharose 4B-200, PEP (monopotassium salt), ADP 
(sodium salt grade I), D-fructose 1,6-diphosphate (tetra sodium salt), 
8-mercaptoethanol, NADH and NADP+ were obtained from Sigma Chemical Co. 
Methods 
Enzyme Assay: Two methods were used to assay for pyruvate kinase activ-
ity. For determination of specific activity the 2,4-dinitrophenylhydra-
zone method was employed. This assay procedure was performed according 
to the method of Tanaka et al. (20) with the exception that 2,4-dinitro-
phenylhydrazine was 0.0125% in 2N HCl and optical density was measured 
at 440 nm. The former modification gave greater sensitivity and the 
latter gave a more acceptable standard curve. 
In the second assay procedure, the enzyme system was coupled with 
lactate dehydrogenase, and the oxidation of NADH was followed at 340 nm 
in a Hitachi Perkin-Elmer recording spectrophotometer fitted with a 124-
5 
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801 scale expander (10). This method was used both for following enzyme 
elution from columns and for kinetic studies. 
The standard assay mixture for column monitoring was as follows: 
+ SO mM Tris (hydroxymethyl)-aminomethane SO mM K and S mM S-mercapto-
ethanol (pH 7.S) final volume 2 ml (20). PEP, ADP and NADH were 0.6, 
l.S and 0.14 mM respectively, and 10 units of lactate dehydrogenase were 
added per assay. Temperature for these studies was 2S0 c. 
lows: 
Composition of the assay mixture for kinetic studies was as fol-
+ . 
50 mM phosphate, 90 mM K and 5 mM S-mercaptoethanol (pH 7.S) 
final volume 2 ml (36). Concentrations of PEP, ADP, NADH and lactate 
dehydrogenase were the same as for column monitoring. Temperature for 
0 these studies was 37 C. · 
Protein Estimations During Purification: The method of Lowry et al. 
was used. In some cases the modified method was used for S to 25 µg of 
protein monitored at 750 nm (37). Blanks with appropriate buffer were 
run for each sample. 
Synthesis of w-aminoalkyl-agarose: Essentially the method of Shaltiel 
and Er-el (38) was employed. Sepharose 4B was suspended in three times 
its volume of 1:1 dimethylformamide and 0.1 M NaHCOs buffer. The pH 
was adjusted to 10.S. Added to this solution was 1 gram of CNBr for 
every 10 grams (wet weight) of Sepharose 4B. The temperature was main-
tained at 22°c by the addition of ice chips and the pH was held between 
10.S and 11 by the addition of 6N NaOH. The reaction was terminated by 
filtration of the gel, which was washed with several volumes of cold 
deionized water. 
When CNBr-activated-Sepharose 4B from Sigma was used, an appropri-
ate amount of freeze-dried gel was weighed out (1 gram freeze-dried 
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material gave a final volume of approximately 3.5 ml). The dried gel 
was transferred to a glass fritted funnel and washed with several addi-
tions of 1 mM HCl solution (200 ml per gram dried gel). After each 
addition of HCl solution the supernatant was removed by filtration. 
Immediately after washing the hydrated gel was treated with a,w-diamino-
alkane. 
The activated gel (purchased or prepared) was suspended in twice 
its volume of cold 100 mM NaHC03, pH 9. The a,w-diaminoalkane to be 
coupled was dissolved in 100 mM NaNC03, pH 9. 4 moles of a,w-diamino-
alkane were added per mole of CNBr used for activation. The moles of 
CNBr used by Sigma for the activation of their Sepharose 4B was given 
in the Axen et al. (39) publication. The final volume of the a,w-di-
aminoalkane solution was equal to the volume of the gel solution. The 
two solutions were mixed and stirred very gently for 24 hours in the 
cold room. Finally, the gel was washed with (100 ml each) water, 100 mM 
NaHC03, 0.05 N NaOH, water, 0.1 M Acetic acid, and water. 
CHAPTER III 
EXPERIMENTAL PROCEDURE 
Purification Procedure 
Holtzman rats were maintained on standard laboratory chow and 
water ad libitum. 3 or 4 rats were decapitated using a guillotine, the 
livers excised and placed in a cold H-buffer consisting of 5 mM Tris, 
pH 7.4, 150 mM KCl, 5 mM MgS04, 1 mM EDTA and 5 mM S-mercaptoethanol. 
The livers were weighed and transferred to a pre-cooled Eberbach, semi-
micro, stainless steel blender with 2 ml H-buffer per gram liver. All 
0 purification steps were performed at 0-4 C unless otherwise stated. 
The livers were homogenized twice for one minute, with adequate cooling 
between intervals. The homogenate was decanted into a beaker and al-
lowed to stand for approximately 30 minutes. The foam which had risen 
to the top was spooned off and the remaining homogenate was centrifuged 
at 56,000g for one hour. The centrifugation was performed using a Type 
30 head in a refrigerated Beckman Spinco model L preparative ultracen-
trifuge. 
The supernatant solutions were carefully decanted, pooled and 
slowly brought to 25% saturation with 13.8 grams of powdered ammonium 
sulfate per 100 ml (if necessary the pH was adjusted to 7.4 with 2N 
NH40H). After standing for twenty minutes the solution was centrifuged 
at 10,000g for 30 minutes in a refrigerated Servall RC-2B with a SS-34 
head or a Servall SS-1 tabletop centrifuge in the cold room. The super-
8 
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natant was saved and slowly increased from 25% to 45% saturation by the 
addition of 11.9 grams of powdered anunonium sulfate per 100 ml (when 
necessary the pH was adjusted as mentioned before). The mixture was 
allowed to stand for 30 minutes before centrifugation as described a-
bove. 
The precipitated enzyme was then gently mixed with 35 ml (packed 
volume) of Celite (40) which had been washed extensively with H-buffer 
saturated to 45% with ammonium sulfate. A column, 1.5 X 25 cm, was 
packed with 5 ml of washed Celite; onto this the Celite-protein mixture 
was poured and allowed to pack by gravity. This resulted in a column 
with a total bed volume of 40 ml, 35 ml Celite-protein on top of 5 ml 
pure Celite. After packing a linear gradient of 60 ml 45% anunonium 
sulfate saturated H-buffer and 60 ml 20% anunonium sulfate saturated H-
buffer was applied. A pressure head of one meter of buffer was required 
to keep the flow rate at 0.5 ml/min. Fractions of 4 ml volume were 
collected and those containing activity were pooled. 
In earlier experiments the Celite method differed in the following 
way. The Celite was washed with H-buffer saturated to 45% with anunon-
ium sulfate and dried with suction. 12 ml (pack volume) were then 
mixed with the 45% anunonium sulfate enzyme pellet which had been re-
suspended in a minimal volume of H-buffer saturated to 45% with anunon-
ium sulfate. The mixture was then poured into a column (1 X 16 cm) and 
allowed to pack by gravity or by pumping action with a Beck.man solution 
metering pump. A linear gradient described before was used to elute 
the enzyme. There were two drawbacks to this method 1) in some exper-
iments the enzyme bled from the column in the first one or two 4 ml 
fractions reducing yield, and 2) the flow rate was exceedingly slow 
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even with the help of the Beck.man metering pump. However, the purifi-
cation achieved was equivalent in both methods. Because elution volume 
of the enzyme (in both techniques) was variable, when necessary the 
Celite effluent was concentrated to 35 ml by the collodion-bag tech-
nique (Bulletin No. 145; Schleicher and Schuell, Keene, N. H., USA). 
The enzyme was sometimes dialyzed against ten times its volume of 
H-buffer and then against the same volume of 1065 buffer consisting of 
10 mM phosphate, pH 6.5, 18 mM K+, 5 mM MgS04, and 5 mM B-mercapto-
ethanol. This procedure required at least 12 hours. A Sephadex G-25 
column was also employed. The enzyme solution was passed through a 
Sephadex G-25 column (250 ml bed volume) equilibrated with 10 mM phos-
+ phate, pH 6.5, 18 mM K , 5 mM B-mercaptoehtanol. The column void volume 
was about 65 ml at a flow rate of 3 ml/minute. The enzyme eluted just 
behind the void volume and was diluted approximately two fold. 
The enzyme solution was immediately applied to an w-aminoalkly-
agarose column (10 ml bed volume). While several hydrophobic columns 
with differing hydrocarbon "arms" were used, the methods employed for 
enzyme application, washing and enzyme elution were the same for each. 
The w-aminoalkyl-agarose columns were synthesized by the method of 
Shaltiel and Er-el (38). The columns were equilibrated with 1065 buffer. 
During the application of enzyme solution the elution of unabsorbed 
protein was followed by the absorbance at 280 nm. When the enzyme 
application was complete the column was washed until the effluent ab-
sorbance was approximately equal to that of the 1065 buffer blank. 
When the enzyme was retained on the column a linear gradient of 50 ml 
1065 buffer and 50 ml 50 mM phosphate, pH 6.5, 90 mM K+, 5 mM MgS0 4 and 
5 mM B-mercaptoethanol was effective in elution. The flow was variable 
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(0.25 ml - 1 ml/min.) but 3 ml fractions were collected and fractions 
with activity were pooled. 
This enzyme solution was then dialyzed twice against ten times its 
volume of 1065 buffer for 8 to 12 hours. 
The dialyzed enzyme was then applied to an N6 -(6-aminohexyl)-AMP-
Sepharose column (5 ml bed volume) equilibrated with 1065 buffer. Un-
bound protein was washed from the column with 1065 buffer and the 
elution of protein was monitored as before. The enzyme was eluted with 
50 ml 1065 buffer and 50 ml 100 mM phosphate, pH 7.5, 5 mM MgS0 4 , 180 
+ 
mM K and 5 mM B-mercaptoethanol. The gradient was linear and again 
flow rate was somewhat variable. (0.5 ml - 1 ml/min.). Two ml fractions 
were collected and those with activity pooled. To enhance stability 
the enzyme was concentrated by the collodion-bag technique to a volume 
of 1 ml. 
CHAPTER IV 
RESULTS AND DISCUSSION 
Antibodies for M type isozyme were not available so that the 
homogenate assays reflect the presence of both isozymes. Also, some 
difficulty was encountered with the homogenate assay using the 2,4 di-
nitrophenylhydrazine technique. The blank for this assay consistently 
gave an inordinately high absorbance. Accuracy was, therefore, some-
what suspect. 
The methods used for the homogenization and the separation of M 
and L type isozymes by ammonium sulfate are well documented. The spec-
ific activities and yields presented in Table I for these methods are 
in good agreement with other researchers. 
Some explanation should be given for the choice of homogenization 
buffers. Previous reports from this lab and others (32,36) have indi-
cated pyruvate kinase to have increased stability in phosphate buffers. 
Phosphate would be the buffer of choice but to avoid the precipitation 
of MgNH 4 P0 4 during the addition of ammonium sulfate and the use of the 
Celite column, a Tris buffer was used. (Results not presented herein 
indicated only a slight instability in Tris over short periods of time). 
The buffer was then changed to phosphate both for stability and conven-
ience. 
The Celite technique was found to be an effective method for a-
chieving significant purification. When perfected, this step took 
12 
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little time to accomplish and results were reproducible. It bas been 
reported by King (40) that several parameters effect this procedure, 
these being the ratio in weight of protein to Celite used, the steep-
ness of the decreasing _salt gradient and control of pH. Also, the 
temperature may be significant. 
For purification of type L pyruvate kinase the Celite to protein 
ratio, between 30 and 90 grams (dry weight) of Celite per gram protein, 
was not found to be critical. But, this ratio was important for practi-
cal reasons. The flow rate of the lower ratio was about half that of 
the higher ratio. The best results were obtained when the gradient had 
a decrease of 0.2% saturation in ammonium sulfate per milliliter. 
Gradients with greater change in percent saturation in ammonium sulfate 
per ml were tried but results were not as good. The pH was controlled 
0 
at 7.4 with the temperature between 0-4 C. Figure #1 shows the peak 
position at 34% ammonium sulfate saturation. A specific activity as 
high as 2.1 has been obtained with this method. 
In preparation for employing hydrophobicity in purification, four 
.:~.(. 
w-aminoalkane sepharose columns (2 ml bed volume) were examined to de-
termine which if any would retain the type L enzyme (the eJzyme was 
suspended in 1065 buffer for these experiments). Seph-C 4 NH 2 , Seph-C 5 -
NH2 and Seph-C 6 -NH2 successfully retained the enzyme but, Seph-C 3 -NH2 
would not. The enzyme w9uld be eluted with the buffer described in 
Chapter III. It should be noted that enzymes bound to alkylamine 
agarose of different chain lengths may be eluted by the same buffer 
system (41). Seph-C 4-NH2 and Seph-C 5 -NH 2 were used for further purifi-
cation studies. Between 20 and 30 mg of protein per gel were added 
to these columns. The results given in Table II show an approximate 
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two fold difference in the purification achieved. 
Based on these preliminary experiments, Seph-C4-NH2 was chosen for 
use in the final purification scheme. The protein loaded was 20 to 25 
mg per ml gel. Purification of this step was about 6 fold providing an 
over.all purification of 59 fold (see Table I). 
An attempt will be made to explain the difference in Seph-C4-NH2 
and Seph-C 5 -NH2 purification. Jennissen and Hielmeyer (42) have shown 
two ways to obtain the critical hydrophobicity needed to absorb protein 
to an alkylamine agarose gel. The degree of alkylamine residue substi-
tution may be increased or the degree of substitution may be held con-
stant and the alkylamine elongated by one or more carbon atoms. It 
seems unlikely that the use of a,w-diaminoalkanes would alter this 
principle. 
The scope of this research made it impractical to quantitatively 
determine the residues of a,w-diaminoalkane bound per agarose sphere. 
It was not possible therefore, to determine accurately the hydrophobi-
city of the Seph-C4-NH2 or Seph-Cs-NH2. But, considering that the 
coupling conditions of the a,w-diaminoalkane for each column were the 
same, it is likely the Seph-Cs-NH2 had the greater hydrophobicity. The 
Seph-Cs-NH2 could then absorb additional protein not absorbed by the 
Seph-C4-NH2. This protein might then be eluted with the enzyme as in-
deed the results indicate. 
In addition to hydrophobic forces, ionic interaction undoubtedly 
contributed to enzyme retention (38). 
N6 -(6-aminohexyl)-AMP (containing 6.5 µmoles of AMP per ml of gel), 
AMP bound to the agarose through the ribose hydroxyls with a six carbon 
space (containing 3.7 µmoles of AMP per ml gel) and ATP bound to the 
15 
agarose through the ribose hydroxyls with a six carbon spacer (contain-
ing 7.3 µmoles of ATP per ml gel) were obtained commercially. Prelimin-
ary experiments were performed to determine which if any would be 
helpful with purification. The enzyme used for these studies had been 
purified through the Celite procedure and then desalted by dialysis 
against H-buffer, then buffer consisting of 5 mM phosphate pH 7.5, 159 
mM K+, 5 mM MgS04 and 5 mM S-mercaptoethanol. This enzyme was applied 
to the three affinity columns (5 ml bed volume each). The columns were 
washed with the application buffer. N6 -(6-aminohexyl)-AMP alone re-
tained the enzyme, but bleeding was observed. Changing the application 
solution to 1065 buffer arrested the bleeding. 
Approximately 4 mg of protein per ml of gel were loaded on the 
N6 -(6-aminohexyl)-AMP column when the column was used in conjunction 
with the previously described purification steps. The purification was 
3 fold and the yield was 18%. Overall purification was 180 fold. 
The attempts to retain the enzyme on the before mentioned columns 
suggest the enzyme may have a preference in binding to an adenine 
nucleotide affinity column. But results presented here cannot be 
considered conclusive due to column differences in µmoles of ligand 
bound per ml gel (43). Before elucidation of the binding is possible 
additional studies must be performed. 
Some kinetic properties of the enzyme which has been purified 
through all steps including N6 -(6-aminohexyl)-AMP were examined. Fruc-
tose 1,6-diphosphate activation assayed as described in Methods was 3 
to 4 fold. The kinetic values for ATP inhibition and the reversal of 
this inhibition by fructose 1,6-diphosphate were in agreement with pub-
lished values (23). The enzyme was preincubated in the assay mixture 
16 
(described in Methods) containing 3 mM ATP alone or together with 1 mM 
fructose 1,6-diphosphate. The reaction was started by the addition of 
phosphoenolpyruvate. The reaction with ATP alone showed 24% activity 
and the reaction with both ATP and fructose 1,6-diphosphate showed 50% 
activity. The enzyme reaction with fructose 1,6-diphosphate and no 
ATP was taken as 100% activity. 
Figure 1. Ammonium sulfate gradient solubilization of type L pyru-
vate kinase from rat liver on a column of Celite. 
Enzyme activity is shown by the solid line, the de-
creasing salt concentration by the broken line. The 
salt saturation at the peak position is given above 
the curve. 
Homog 
Ammonium 
Sulfate 
Ce lite 
Seph-C4-NH2 
N6-AMP 
TABLE I 
PURIFICATION OF RAT LIVER TYPE L 
PYRUVATE KINASE 
Total 
activity 
(Units) 
1021 
594 
341 
182 
182 
Total 
protein 
(mg) 
5998 
1036 
226 
18 
6 
Specific 
activity 
Units/mg 
.17 
.57 
1.5 
10 
30 
18 
Recovery 
(%) 
100 
58 
33 
18 
18 
Figure 2. Purification of type L pyrqvate kinase on Seph-C4-NH2. 
After the unabsorbed protein (monitored by the absorb-
ance at 280 nm shown as •) was washed off, a linear 
phosphate gradient (---) was applied to elute the 
enzyme (~). 
Abbreviation 
Seph-C3-NH2 
Seph-C4-NH2 
Seph-C5-NH2 
Seph-C6-N H2 
TABLE II 
BINDING AND PURIFICATION OF RAT 
LIVER TYPE L PYRUVATE KINASE 
BY AMINOALKYL-AGAROSE 
Structure 
m-NH-(CH2)3NH2 
. e-NH-(CH2)4NH2 
D--NH-(CH2)5-NH2 
D-NH-(CH2)5NH2 
Enzyme 
Retained 
No 
Yes 
Yes 
Yes 
Specific 
Activity 
nd 
10 
5.6 
nd 
Specific activity of enzyme applied to each column was 1. 5. 
Figure 3. Purification of type L pyruvate kinase on N6 -(6-amino-
hexyl)-AMP. Unabsorbed protein washed off before the 
gradient is not shown. A linear phosphate gradient was 
used to elute the enzyme(~). The elution of protein 
was monitored by the absorbance at 280 (•). The inset 
shows the structure of the immobilized nucleotide ab-
sorbent. 
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CHAPTER V 
SUMMARY 
Tris buffer (5 mM) was used for homogenization, ammonium sulfate, 
and Celite steps during the purification of Type L pyruvate kinase from 
rat liver. 
The Celite technique when perfected gave reproducible results and 
significant purification. The Celite to protein ratio was 30 to 90 
grams (dry weight) Celite per gram protein. The gradient had a decrease 
of 0.2% saturation in ammonium sulfate per ml and the pH was controlled 
at 7.4. A specific activity as high as 2.1 was obtained with this 
method. 
A Seph-C 4 -NH2 gel was selected for the hydrophobic column. The 
protein load was 20 to 25 mg per ml gel. A linear gradient of 10 mM 
phosphate to 50 mM phosphate was effective in eluting the enzyme. Cum-
ulative purification was 59; step purification was 6; specific activity 
was 10. 
Three adenine nucleotide affinity columns were used for affinity 
chromatography studies of these only N6 -(6-aminohexyl)-AMP would retain 
the enzyme. Approximately 4 mg of protein per ml gel was bound to this 
column when it was used in conjunction with all other steps. The cumu-
lative enzyme purification achieved was 180 fold (step purification 
was 3) and the yield from the previous step was 98%. 
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